Page last updated: 2024-11-05

zolpidem and Ophthalmoplegia, Progressive Supranuclear

zolpidem has been researched along with Ophthalmoplegia, Progressive Supranuclear in 3 studies

Zolpidem: An imidazopyridine derivative and short-acting GABA-A receptor agonist that is used for the treatment of INSOMNIA.
zolpidem : An imidazo[1,2-a]pyridine compound having a 4-tolyl group at the 2-position, an N,N-dimethylcarbamoylmethyl group at the 3-position and a methyl substituent at the 6-position.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cotter, C1
Armytage, T1
Crimmins, D1
Daniele, A1
Moro, E1
Bentivoglio, AR1
Mayr, BJ1
Bonelli, RM1
Niederwieser, G1
Költringer, P1
Reisecker, F1

Trials

1 trial available for zolpidem and Ophthalmoplegia, Progressive Supranuclear

ArticleYear
Zolpidem in progressive supranuclear palsy.
    The New England journal of medicine, 1999, Aug-12, Volume: 341, Issue:7

    Topics: Cross-Over Studies; Humans; Hypnotics and Sedatives; Levodopa; Male; Middle Aged; Pilot Projects; Py

1999

Other Studies

2 other studies available for zolpidem and Ophthalmoplegia, Progressive Supranuclear

ArticleYear
The use of zolpidem in the treatment of progressive supranuclear palsy.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2010, Volume: 17, Issue:3

    Topics: GABA Agonists; Humans; Male; Middle Aged; Pyridines; Supranuclear Palsy, Progressive; Zolpidem

2010
Zolpidem in progressive supranuclear palsy.
    European journal of neurology, 2002, Volume: 9, Issue:2

    Topics: GABA Agonists; Humans; Male; Middle Aged; Pyridines; Supranuclear Palsy, Progressive; Zolpidem

2002